TransMedics Group, Inc. Common Stock TMDX
Analyst Ratings
- Consensus
- Moderate Buy — 7 Buy · 4 Hold · 0 Sell (11 analysts)
- Avg. Price Target
- $110.18 (+24.9% upside)
Key Stats
- Today's Range
- $76.50 – $88.44
- 50-Day Range
- $64.64 – $93.45
- 52-Week Range
- $60.10 – $156.00
- Volume
- 3.95 million shs
- Average Volume
- 1.02 million shs
- Market Cap
- $3.06 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 1.18%
- Days to Cover
- 1.00
About TransMedics Group, Inc. Common Stock
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Related Stocks
Compare head-to-head: TMDX vs MDT·TMDX vs AXGN·TMDX vs CNMD·TMDX vs CBLL
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.